Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus

NCT05029115 is registered in ClinicalTrials.gov with Ewha Womans University Mokdong Hospital as lead sponsor.

NCT NCT05029115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05029115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus
Lead sponsor
Ewha Womans University Mokdong Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 5, 2021
Completion date
December 31, 2026
Enrollment
716 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, diabetes mellitus, type 2, sglt-2 inhibitor